Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-06-22 07:57 CEST (UTC+2h)

IP retention EU regulatory requirements [Regulatives / Guidelines]

posted by manusyriac - India, 2018-03-08 10:20  - Posting: # 18505
Views: 445

Hi All,

I would like to seek your help in getting your thoughts on the EU regulatory requirements on the investigational medicinal product retention at sponsor manufacturing sites. Especially my focus area is the quantity of IP to be stored at manufacturing site.

Please guide me.

Regards
Manu

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,413 posts in 3,912 threads, 1,175 registered users;
online 35 (0 registered, 35 guests [including 28 identified bots]).

The greatest shortcoming of the human race is our inability
to understand the exponential function.    Albert Bartlett

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed